November 2017: The Research Advocate


The November 2017 Research Advocate is now online

Highlights from this month's issue: 

More state and federal support for medical and health research could help solve West Virginia’s opioid crisis and reposition the state as a research leader, according to panelists at Research!America’s program “West Virginia Research and Innovation: A Catalyst for Better Health and Economic Growth” on October 16 at Shepherd University.

On Friday, October 13, Research!America hosted a webinar, “Innovative Research and the Opioid Epidemic: Are We Closer to Finding Solutions?” Speakers discussed how researchers, public health officials and pharmacists serve pivotal roles in combating this ongoing crisis.

Join Research!America and leading public health organizations on Public Health Thank You Day, Monday, November 20, to recognize public health professionals who work tirelessly to protect the health of all Americans.

Research!America will be hosting a congressional briefing, "From Discovery to Delivery: Research at Work - COPD," Wednesday, November 15, 12:30-1:30 in the Senate Capitol Visitors Center, SD-G50.

Both migraine sufferers and non-sufferers are concerned about the disease’s impact on work productivity, quality of life, family/relationships and employment, according to a survey commissioned by Research!America.

A member spotlight featuring the the National Alliance on Mental Illness (NAMI), the nation’s largest grassroots mental health organization dedicated to building better lives for the millions of Americans affected by mental illness.

Download the entire November 2017 Research Advocate as a PDF.


Add comment

Plain text

  • No HTML tags allowed.
  • Adds node titles to internal links found in content (as HTML "title" attribute).
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
The capabilities are enormous, a little bit of research can pay off quite a bit in the long run.
Paul D’ Addario, retinitis pigmentosa patient